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Aims: To report a rare case of oropharyngeal anthrax.
Materials and Methods: A case report of oropharyngeal anthrax is presented together with the related
world literature.
Results: A 70-year-old female patient with respiratory distress and extensive swelling of neck, soft palate and
uvula is presented. There was ecchymosis on the neck circumferentially. Bacillus anthracis grew in the blood
culture. The patient died of toxemia and sepsis.
Conclusions: Oropharyngeal anthrax is the least common form of anthrax. This acute illness should be added
to the differential diagnosis of inflammatory lesion of the oropharynx with extensive neck swelling. Successful
diagnosis of anthrax depends on a high level of suspicion.
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Amaç:Orofarengeal şarbonlu nadir bir vaka sunmak.
Yöntem ve Gereç: Orofarengeal şarbonlu bir olgu literatür ile birlikte değerlendirilmiştir.
Bulgular: Solunum sıkıntısı ve boyunda, yumuşak damak ve uvulada ileri derecede şişlik ile başvuran 70
yaşında kadın hasta sunulmuştur. Boyunda yaygın ekimoz vardı. Kan kültüründe Bacillus anthracis üredi. Hasta
toksemi ve sepsis nedeniyle kaybedildi.
Sonuç: Orofarengeal şarbon en az sıklıkla bulunan şarbon formudur. Bu akut hastalık yaygın boyun şişliği ile
seyreden orofarengeal inflamatuvar lezyonlarının ayırıcı tanısında akılda bulundurulmalıdır. Şarbonun başarılı
tanısı, bundan şüphelenmeye bağlıdır.
Anahtar Sözcükler: Şarbon, orofarenks, toksik şok
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Anthrax is often a fatal bacterial infection occurring when Bacillus anthracis (B.
anthracis) endospores enter the body through abrasions in the skin or by inhalation or
ingestion. Human infections result from contact with contaminated animals or animals
products; there are no known cases of human-to-human transmission (1,2). B.
anthracis is primarily found in tropical environments in Africa, Asia, South and Central
America and the Caribbean (3). There are four clinical types of human anthrax:
cutaneous, inhalational, gastrointestinal, and oropharyngeal. Cutaneous anthrax
accounts for more than 90% of the cases worldwide, while oropharyngeal anthrax is the
least common form (3). Oropharyngeal anthrax develops after ingestion of infected
meat and subsequent invasion of mucosal and submucosal lymphatics (4). Initial
symptoms include cervical edema and local lymphadenopathy, which cause dysphagia and
respiratory difficulties (5). Patients with oropharyngeal anthrax may also complain of
fever, hoarseness, cough, globus sensation, and neck pain. Intraoral examination
typically reveals inflammatory lesions (red–purple ulcerations) or asymmetric swelling of
oral cavity or oropharynx. If localized to the tonsillar region, it may mimic a peritonsillar
abscess; however, there is no pus (6).
* This paper was presented in part at the 29th Turkish National Otorhinolaryngology and Head and Neck
Surgery Congress, Antalya, Turkey, 26-31 May 2007.
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In this article, we report a case with oropharyngeal
anthrax, with the complaints of respiratory distress and
extensive swelling of the neck.

Case Report
A 70-year-old previously healthy female was admitted
to a state hospital with respiratory distress complaint.
Oropharyngeal edema was detected and intravenous and
inhaler corticosteroid were applied, as angioneurotic
edema was suspected. This medication and observation
failed to reduce her complaints. She was consigned to our
medical faculty hospital. The symptoms began after
basement sweeping. The respiratory distress and swelling
of the neck became rapidly more severe after two days.
She was admitted about two days after the onset of
symptoms. At the time of admission, the patient was in
severe respiratory distress. Her blood pressure was
140/90 mmHg, pulse rate 88/minute and axillary
o
temperature 35.7 C. There was swelling and ecchymosis
on the neck circumferentially. Throat examination
revealed marked swelling of the soft palate and uvula.
There was no necrosis or ulceration in this area.
Laboratory data included a hematocrit of 47.8% and a
3
white blood cell count of 14,800 mm with 93.3%
neutrophils and 6.3% lymphocytes. Chest X-rays were
normal. The blood gas analysis showed mild respiratory
acidosis. Blood culture was taken three times at 30minute intervals. Ceftriaxone every 12 hours was started
intravenously together with acidosis treatment. The

Figure. Bacillus anthracis in liver. Polymorphonuclear leukocyte
(arrow) and B. anthracis (arrow head) (Gram stain X1000).
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patient lost consciousness 18 hours after admission.
Blood pressure decreased to 60/40 mmHg. The patient
was intubated with endotracheal intubation tube and
ventilation was adjusted. Body temperature increased up
to 37.3oC. The patient died 64 hours after admission. A
postmortem hepatic needle biopsy was performed, and B.
anthracis was isolated both in the blood culture and
hepatic biopsy material (Figure). There was no contact
with infected animals or contaminated animal products.
The source of infection could not be established. Other
family members were healthy.

Discussion
Anthrax infections are initiated by endospores of B.
anthracis, a gram-positive soil organism. Anthrax
endospores do not grow, have no measurable
metabolism, and are resistant to drying, heat, ultraviolet
light, gamma radiation, and many disinfectants. In some
types of soil, anthrax spores can remain dormant for
decades (5). Anthrax toxin contains three proteins:
protective antigen (PA), edema factor (EF), and lethal
factor (LF). These toxins decrease polymorphonuclear
function and cause toxic clinical manifestations (7).
Oropharyngeal anthrax is usually associated with
ingestion of contaminated meat (4,6-9). There was no
ingestion of contaminated meat in our patient’s history.
Sirisanthana et al. (6) reported that the oropharyngeal
form of anthrax is a potentially fatal, febrile illness
characterized by a short incubation period and an
oral/oropharyngeal lesion that can progress from edema
and congestion to a pseudomembranous necrosis,
associated with pharyngeal and cervical lymphadenopathy
and surrounding edema. Systemic anthrax involves
massive bacteremia and toxemia with nondescript initial
symptoms until the onset of hypotension, shock, and
sudden death. Manifestations of advanced disease,
including shock and sudden death are believed to result
from the action of the exotoxin complex secreted by
anthrax bacilli (2). Most of the patients who died of
anthrax sepsis, despite treatment, had incubation periods
of less than 48 h and typically died within 48 h of the
onset of symptoms (7). Doganay et al. (8) reported six
cases with oropharyngeal anthrax. The lesions were
localized on tonsils in five cases and on the base of the
tongue in one case. The source of infection was not
established in two cases. In our case, the lesion was
localized on the soft plate and uvula. The source of
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infection could not be established. Penicillin is the drug of
choice in the treatment of anthrax. Despite penicillin
treatment, the mortality rate of pulmonary and
gastrointestinal system anthrax or septicemia and
meningitis is >80% (8). Death may occur secondary to a
toxin from B. anthracis (4,8). In our patient, despite
antimicrobial treatment (ceftriaxone) and supportive
care, the patient died 64 hours after admission. In our
opinion, death results from toxemia. The diagnosis is
rarely made before death except in endemic areas (7). In
this case, there was no suspicion of anthrax. Our region
is not an endemic area for anthrax. Differential diagnosis
of oropharyngeal anthrax should include peritonsillar
abscess, parapharyngeal space abscess, streptococcal
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pharyngitis, Ludwig’s angina, and diphtheria (3). Blood
cultures of systemic anthrax infection cases are almost
always positive because of the large numbers of bacterial
cells in the circulation (1). All oropharyngeal cases must
be carefully observed, because rapid edema may develop
and necessitate endotracheal intubation or even
tracheotomy. Corticosteroids may be indicated in addition
to appropriate antibiotic therapy (2,3).
In conclusion, oropharyngeal anthrax is the least
common form of anthrax. This acute illness should be
added to the differential diagnosis of inflammatory lesion
of the oropharynx with extensive neck swelling.
Successful diagnosis of anthrax depends on a high level of
suspicion.
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